ProCE Banner Activity

Hepatologist Audio From Hot Topics in NASH: Screening for NASH in Patients With Diabetes

Audio

Listen as expert hepatologist faculty explore NASH screening and interplay between NAFLD, metabolic syndrome, CV risk, diabetes risk.

Released: December 03, 2019

Expiration: December 01, 2020

No longer available for credit.

Share

Faculty

Brent A. Neuschwander-Tetri

Brent A. Neuschwander-Tetri, MD

Professor of Internal Medicine
Saint Louis University Liver Center
Division of Gastroenterology and Hepatology
Saint Louis University School of Medicine
St. Louis, Missouri

Provided by

Provided by the American Gastroenterology Association.

ProCE Banner

Supporters

Supported by educational grants from

Allergan

Gilead

Intercept Pharmaceuticals

Partners

Endocrine Society

ProCE Banner

Faculty Disclosure

Primary Author

Brent A. Neuschwander-Tetri, MD

Professor of Internal Medicine
Saint Louis University Liver Center
Division of Gastroenterology and Hepatology
Saint Louis University School of Medicine
St. Louis, Missouri

Brent A. Neuschwander-Tetri, MD, has disclosed that he has received consulting fees from Allergan, Allysta, Arrowhead, ARTham, Axcella, Blade, Boehringer Ingelheim, Bristol-Myers Squibb, Coherus, Consynance, CymaBay, Durect, Enanta, Ferring, Fortress, Gelesis, Genfit, Gilead Sciences, High Tide, HistoIndex, Intercept, Lipocine, Llama, Madrigal, MedImmune, Merck, Metacrine, Mundipharma, NGM, pH-Pharma, Prometheus, and Siemens and funds for research support paid to Saint Louis University from Allergan, Bristol-Myers Squibb, Cirius, CymaBay, Enanta, Galectin, Genfit, Gilead Sciences, Intercept, Madrigal, NGM, and Prometheus.